David Propper
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 38
- Pancreatic and Hepatic Oncology Research 15
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 5
- Co-authors
- Frances R. Balkwill (6 shared papers)Adrian L. Harris (16 shared papers)Jeremy Braybrooke (12 shared papers)Trivadi S. Ganesan (12 shared papers)Denis Talbot (9 shared papers)Roger Feakins (4 shared papers)Kenneth J. O’Byrne (9 shared papers)Jonathan Shamash (3 shared papers)
- Journals
- British Journal of Cancer (10 papers)Journal of Clinical Oncology (10 papers)Annals of Oncology (7 papers)Cancer Research (4 papers)Transplantation (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
David Propper
74 papers receiving 3.1k citations
David Propper's Hit Papers
Peers
Comparison fields: 5 of 122
- Internal Medicine 193
- Oncology 1.2k
- Cancer Research 473
- Immunology 595
- Hematology 230
Countries citing papers authored by David Propper
This map shows the geographic impact of David Propper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Propper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Propper more than expected).
Fields of papers citing papers by David Propper
This network shows the impact of papers produced by David Propper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Propper. The network helps show where David Propper may publish in the future.
Co-authors
The 25 scholars most cited alongside David Propper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Harnessing cytokines and chemokines for cancer therapy Hit paper breakdown → | 2022 | 710 |
| 2 | 2011 | 236 | |
| 3 | 2013 | 192 | |
| 4 | 2001 | 191 | |
| 5 | 2011 | 177 | |
| 6 | 2008 | 140 | |
| 7 | 2018 | 122 | |
| 8 | 2018 | 115 | |
| 9 | Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. | 2001 | 106 |
| 10 | 1999 | 103 | |
| 11 | 2018 | 98 | |
| 12 | Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma. | 2003 | 92 |
| 13 | 2004 | 74 | |
| 14 | 2009 | 55 | |
| 15 | A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. | 2000 | 53 |
| 16 | 2017 | 50 | |
| 17 | Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects. | 1999 | 47 |
| 18 | 2003 | 46 | |
| 19 | 2003 | 41 | |
| 20 | The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. | 1999 | 41 |
About David Propper
David Propper is a scholar working on Oncology, Molecular Biology, Cancer Research, Hematology and Immunology, having authored 78 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), Cancer, Hypoxia, and Metabolism (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Blood groups and transfusion (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Research and Treatments (6 papers), Cancer Treatment and Pharmacology (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). The work is most often cited by research in Internal Medicine (193 citations), Oncology (1.2k citations), Cancer Research (473 citations), Immunology (595 citations) and Hematology (230 citations). David Propper has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Frances R. Balkwill, Adrian L. Harris, Jeremy Braybrooke, Trivadi S. Ganesan, Denis Talbot, Roger Feakins, Kenneth J. O’Byrne, Jonathan Shamash, Eric Gardiner and F. Lofts. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.